Supremo entendeu que a Justiça do Trabalho não tem competência para julgar o processo.
A Eli Lilly reforçou sua liderança no mercado de medicamentos para obesidade ao apresentar novos resultados da retatrutida durante a reunião da American Diabetes Association (ADA), realizada neste mês em Nova Orleans. Os dados mostraram que o medicamento experimental foi capaz de proporcionar perda de até 30% do peso corporal ao longo de aproximadamente dois […]
O post Nova droga da Eli Lilly…
Explosive demand and high prices for Novo Nordisk NOVOb.CO and Eli Lilly’s LLY.N weight loss and diabetes drugs have fueled a criminal effort to package autoinjector pens containing other substances, such as insulin, with branding and batch numbers that make them look like Novo’s Ozempic. If patients suspect they have bought a fake version of Ozempic or another drug, […]
The post Factbox: How to…
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.
Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are uncertain.
D
Wegovy, um medicamento aprovado para perda de peso, começou a ser produzido inicialmente em uma fábrica da Novo Nordisk em Kalundborg
Durante anos, o topo da indústria farmacêutica foi dominado por terapias contra o câncer. Agora, o mercado assiste a uma mudança de rota bilionária. O Mounjaro, da Eli Lilly, tornou-se o medicamento mais vendido do mundo ao alcançar US$ 8,7 bilhões em receita no primeiro trimestre de 2026 e ultrapassar o Keytruda, imunoterapia da Merck […]
O post Mounjaro assume topo da indústria farmacêutica…
France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved lecanemab, commercially known as Leqembi, in October 2025.
Eli Lilly has issued a high alert following the seizure of Rs 56 lakh worth of fake Mounjaro injections in Gurugram. The pharmaceutical company is urging vigilance against counterfeit medications.
What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts has some answers.
Health insurers would have likely faced a financial strain by participating in the Medicare pilot.
Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 billion.
How has the FDA's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine? Find out on this week's episode of "The Readout…
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks
How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
Forbes, a mais conceituada revista de negócios e economia do mundo.
Uma avaliação elevada, combinada à redução na geração de fluxo de caixa, sugere expectativas altas de crescimento
O post A Ação da Eli Lilly É a Melhor Aposta de Crescimento no Setor de Saúde? apareceu primeiro em Forbes Brasil.
The patent wall is starting to crack.
SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three years.
Novo Nordisk announced it had signed a deal with Vivtex, a biotech co-founded by MIT professor Robert Langer, to develop oral obesity and diabetes drugs.
為因應減重藥物市場的白熱化競爭，諾和諾德宣布自2027年起，將調降「週纖達」等GLP-1藥物標價，降幅最高達50%，加劇與對手禮來的價格戰。
Forbes, a mais conceituada revista de negócios e economia do mundo.
Os ativos da Novo recuaram mais de 15% na abertura do mercado
O post Ações da Novo Nordisk Despencam após Rival Eli Lilly Ter Resultados Melhores em Estudo Clínico de Remédio para Emagrecimento apareceu primeiro em Forbes Brasil.
Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion
This week on "The Readout LOUD": We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the rollout of a crucial…
Page 1